Publications by authors named "Yidi Ge"
Article Synopsis
- Acute kidney injury (AKI) frequently occurs in cirrhotic patients in the ICU and is linked to a poor prognosis, leading to a study on the impact of albumin therapy in these patients.
- The analysis, drawn from the MIMIC-IV database, found that while albumin treatment improved AKI recovery within 48 hours, it did not reduce overall 28-day mortality.
- Nonetheless, the use of 5% albumin concentration showed potential mortality benefits, especially in patients with high bilirubin levels, while it may increase mortality risk in certain groups, such as those with chronic kidney disease.
We hypothesized that the response to cardiac resynchronization therapy with a defibrillator (CRT-D) in patients with mildly symptomatic heart failure (HF) is more favorable than the commonly referenced figure of 70%. This study involves the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT) study population in which paired echocardiograms from baseline and 1-year follow-up were available in 621 implantable cardioverter-defibrillator-treated patients and 749 patients treated with CRT-D. We prespecified CRT-D responders as the patients who at 1-year follow-up had a reduction in left ventricular end-systolic volume (LVESV) that corresponded to the top (best) quintile of LVESV reduction in the implantable cardioverter-defibrillator-treated patients, that is, a ≥17% reduction in LVESV.
View Article and Find Full Text PDF